Autopsy report · NCT01612988

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Other drugs others studies”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 5 years 9 months before it stopped.
74 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: French Innovative Leukemia Organisation
Sponsor type: University, hospital or other
Conditions: B-cell Chronic Lymphocytic Leukemia (B-CLL)
Interventions: BOMP
Participants: 74
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.